☰

Sara Y. Tartof, Ph.D. - Publications

Affiliations: 
2010 Epidemiology University of California, Berkeley, Berkeley, CA, United States 
Area:
Microbiology, Immunology, Public Health
Tree Info Similar researchers PubMed Report error

40 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Frutos AM, Price AM, Harker E, Reeves EL, Ahmad HM, Murugan V, Martin ET, House S, Saade EA, Zimmerman RK, Gaglani M, Wernli KJ, Walter EB, Michaels MG, Staat MA, ... ... Tartof SY, et al. Interim Estimates of 2023-24 Seasonal Influenza Vaccine Effectiveness - United States. Mmwr. Morbidity and Mortality Weekly Report. 73: 168-174. PMID 38421935 DOI: 10.15585/mmwr.mm7308a3  0.552
2024 Sumner KM, Yadav R, Noble EK, Sandford R, Joshi D, Tartof SY, Wernli KJ, Martin ET, Gaglani M, Zimmerman RK, Talbot HK, Grijalva CG, Belongia EA, Chung JR, Rogier E, et al. Anti-SARS-CoV-2 Antibody Levels Associated with COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu VE Network, October 2021-June 2022. The Journal of Infectious Diseases. PMID 38390968 DOI: 10.1093/infdis/jiae090  0.468
2023 Sandford R, Yadav R, Noble EK, Sumner K, Joshi D, Tartof SY, Wernli KJ, Martin ET, Gaglani M, Zimmerman RK, Talbot HK, Grijalva CG, Belongia EA, Carlson C, Coughlin M, et al. Antibody response to symptomatic infection with SARS-CoV-2 Omicron variant viruses, December 2021-June 2022. Medrxiv : the Preprint Server For Health Sciences. PMID 38014151 DOI: 10.1101/2023.11.17.23298700  0.455
2023 Ahmed F, Nowalk MP, Zimmerman RK, Bear T, Grijalva CG, Talbot HK, Florea A, Tartof SY, Gaglani M, Smith M, McLean HQ, King JP, Martin ET, Monto AS, Phillips CH, et al. Work Attendance with Acute Respiratory Illness Before and During COVID-19 Pandemic, United States, 2018-2022. Emerging Infectious Diseases. 29. PMID 37917142 DOI: 10.3201/eid2912.231070  0.482
2023 Sumner KM, Yadav R, Noble EK, Sandford R, Joshi D, Tartof SY, Wernli KJ, Martin ET, Gaglani M, Zimmerman RK, Talbot HK, Grijalva CG, Chung JR, Rogier E, Coughlin MM, et al. Anti-SARS-CoV-2 Antibody Levels Associated with COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu VE Network, October 2021-June 2022. Medrxiv : the Preprint Server For Health Sciences. PMID 37790578 DOI: 10.1101/2023.09.21.23295919  0.475
2023 Tartof SY, Xie F, Yadav R, Wernli KJ, Martin ET, Belongia EA, Gaglani M, Zimmerman RK, Talbot HK, Thornburg N, Flannery B. Prior SARS-CoV-2 infection and COVID-19 vaccine effectiveness against outpatient illness during widespread circulation of SARS-CoV-2 Omicron variant, US Flu VE network. Influenza and Other Respiratory Viruses. 17: e13143. PMID 37246146 DOI: 10.1111/irv.13143  0.55
2023 Tartof SY, Xie F, Yadav R, Wernli KJ, Martin ET, Belongia EA, Gaglani M, Zimmerman RK, Talbot HK, Thornburg N, Flannery B, Chung JR. Prior SARS-CoV-2 Infection and COVID-19 Vaccine Effectiveness against Outpatient Illness during Widespread Circulation of SARS-CoV-2 Omicron Variant, US Flu VE Network. Medrxiv : the Preprint Server For Health Sciences. PMID 36711929 DOI: 10.1101/2023.01.10.23284397  0.55
2022 Kim SS, Chung JR, Talbot HK, Grijalva CG, Wernli KJ, Kiniry E, Martin ET, Monto AS, Belongia EA, McLean HQ, Gaglani M, Mamawala M, Nowalk MP, Moehling Geffel K, Tartof SY, et al. Effectiveness of two and three mRNA COVID-19 vaccine doses against Omicron- and Delta-Related outpatient illness among adults, October 2021-February 2022. Influenza and Other Respiratory Viruses. 16: 975-985. PMID 36825251 DOI: 10.1111/irv.13029  0.517
2022 Price AM, Flannery B, Talbot HK, Grijalva CG, Wernli KJ, Phillips CH, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Mutnal M, Geffel KM, Nowalk MP, Tartof SY, et al. Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021-2022 Influenza Season. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 36504336 DOI: 10.1093/cid/ciac941  0.525
2022 Chung JR, Kim SS, Kondor RJ, Smith C, Budd AP, Tartof SY, Florea A, Talbot HK, Grijalva CG, Wernli KJ, Phillips CH, Monto AS, Martin ET, Belongia EA, McLean HQ, et al. Interim Estimates of 2021-22 Seasonal Influenza Vaccine Effectiveness - United States, February 2022. Mmwr. Morbidity and Mortality Weekly Report. 71: 365-370. PMID 35271561 DOI: 10.15585/mmwr.mm7110a1  0.541
2019 Becerra-Culqui TA, Sy LS, Ackerson BK, Slezak JM, Luo Y, Fischetti CA, Ohadike YU, Curina C, Pellegrini M, Solano Z, Tartof SY, Tseng HF. Safety of quadrivalent meningococcal conjugate vaccine in infants and toddlers 2 to 23-months old. Vaccine. PMID 31648912 DOI: 10.1016/J.Annepidem.2019.08.026  0.331
2019 Hechter RC, Qian L, Tartof SY, Sy LS, Klein NP, Weintraub E, Mercado C, Naleway A, McLean HQ, Jacobsen SJ. Vaccine safety in HIV-infected adults within the Vaccine Safety Datalink Project. Vaccine. PMID 31064675 DOI: 10.1016/J.Vaccine.2019.04.080  0.339
2018 Tseng HF, Sy LS, Qian L, Liu IA, Mercado C, Lewin B, Tartof SY, Nelson J, Jackson LA, Daley MF, Weintraub E, Klein NP, Belongia E, Liles EG, Jacobsen SJ. Pneumococcal Conjugate Vaccine Safety in Elderly Adults. Open Forum Infectious Diseases. 5: ofy100. PMID 29977960 DOI: 10.1093/Ofid/Ofy100  0.371
2018 Jackson ML, Yu O, Nelson JC, Nordin JD, Tartof SY, Klein NP, Donahue JG, Irving SA, Glanz JM, McNeil MM, Jackson LA. Safety of repeated doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine in adults and adolescents. Pharmacoepidemiology and Drug Safety. PMID 29862604 DOI: 10.1002/Pds.4569  0.362
2017 Tartof SY, Sy LS, Ackerson BK, Hechter RC, Haag M, Slezak JM, Luo Y, Fischetti CA, Takhar HS, Miao Y, Solano Z, Jacobsen SJ, Tseng HF. Safety of Quadrivalent Meningococcal Conjugate Vaccine in Children 2-10 Years. The Pediatric Infectious Disease Journal. PMID 28719502 DOI: 10.1097/Inf.0000000000001696  0.329
2017 Tartof S, Liu IA, Qian L, Lewin B, Sy LS, Tseng HF, Hechter R, Jacobsen S. Safety of Influenza Vaccination Among Hospitalized Patients Open Forum Infectious Diseases. 4: S451-S451. DOI: 10.1093/Ofid/Ofx163.1150  0.352
2016 Tseng HF, Sy LS, Ackerson BK, Hechter RC, Tartof SY, Haag M, Slezak JM, Luo Y, Fischetti CA, Takhar HS, Miao Y, Cunnington M, Solano Z, Jacobsen SJ. Safety of Quadrivalent Meningococcal Conjugate Vaccine in 11- to 21-Year-Olds. Pediatrics. PMID 28025240 DOI: 10.1542/Peds.2016-2084  0.361
2016 Tartof SY, Qian L, Rieg GK, Yu KC, Sy LS, Tseng HF, Hechter RC, Jacobsen SJ. Safety of Seasonal Influenza Vaccination in Hospitalized Surgical Patients: A Cohort Study. Annals of Internal Medicine. PMID 26974053 DOI: 10.7326/M15-1667  0.378
2016 Tseng HF, Harpaz R, Luo Y, Hales CM, Sy LS, Tartof SY, Bialek S, Hechter RC, Jacobsen SJ. Declining effectiveness of herpes zoster vaccine in adults 60 years and older. The Journal of Infectious Diseases. PMID 26908728 DOI: 10.1093/Infdis/Jiw047  0.368
2016 Tseng HF, Luo Y, Sy L, Tartof S, Hechter R, Jacobsen S. No Increased Risk of Herpes Zoster After Concomitant Administration of Zoster Vaccine and Pneumococcal Polysaccharide Vaccine Open Forum Infectious Diseases. 3. DOI: 10.1093/Ofid/Ofw172.615  0.367
2015 Tseng HF, Luo Y, Shi J, Sy LS, Tartof SY, Sim JJ, Hechter RC, Jacobsen SJ. Effectiveness of Herpes Zoster Vaccine in Patients 60 Years and Older With End-stage Renal Disease. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 26671505 DOI: 10.1093/Cid/Civ930  0.368
2015 Tseng HF, Lewin B, Hales CM, Sy LS, Harpaz R, Bialek S, Luo Y, Jacobsen SJ, Reddy K, Huang PY, Zhang J, Anand S, Bauer EM, Chang J, Tartof SY. Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster Vaccine. The Journal of Infectious Diseases. PMID 26038400 DOI: 10.1093/Infdis/Jiv244  0.371
2015 Gambhir M, Clark TA, Cauchemez S, Tartof SY, Swerdlow DL, Ferguson NM. A change in vaccine efficacy and duration of protection explains recent rises in pertussis incidence in the United States. Plos Computational Biology. 11: e1004138. PMID 25906150 DOI: 10.1371/Journal.Pcbi.1004138  0.377
2015 Tseng HF, Luo Y, Hales C, Bialek SR, Harpaz R, Tartof S, Sy LS, Jacobsen S. Declining Herpes Zoster Vaccine Effectiveness in Adults 60 Years and Older Open Forum Infectious Diseases. 2. DOI: 10.1093/Ofid/Ofv133.1476  0.331
2015 Tseng HF, Luo Y, Tartof S, Hechter R. P4-291: Herpes zoster vaccination and risk of herpes zoster among demential population aged 60 years and older Alzheimer's & Dementia. 11: P897-P897. DOI: 10.1016/J.Jalz.2015.08.121  0.327
2014 Langer-Gould A, Qian L, Tartof SY, Brara SM, Jacobsen SJ, Beaber BE, Sy LS, Chao C, Hechter R, Tseng HF. Vaccines and the risk of multiple sclerosis and other central nervous system demyelinating diseases. Jama Neurology. 71: 1506-13. PMID 25329096 DOI: 10.1001/Jamaneurol.2014.2633  0.313
2014 Tartof SY, Tseng HF, Liu IL, Qian L, Sy LS, Hechter RC, Marcy SM, Jacobsen SJ. Inpatient admission for febrile seizure and subsequent outcomes do not differ in children with vaccine-associated versus non-vaccine associated febrile seizures. Vaccine. 32: 6408-14. PMID 25285882 DOI: 10.1016/J.Vaccine.2014.09.055  0.363
2014 Tseng HF, Tartof S, Harpaz R, Luo Y, Sy LS, Hetcher RC, Jacobsen SJ. Vaccination against zoster remains effective in older adults who later undergo chemotherapy. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 59: 913-9. PMID 25097079 DOI: 10.1093/Cid/Ciu498  0.351
2014 Berman HF, Tartof SY, Reis JN, Reis MG, Riley LW. Distribution of superantigens in group A streptococcal isolates from Salvador, Brazil. Bmc Infectious Diseases. 14: 294. PMID 24885209 DOI: 10.1186/1471-2334-14-294  0.616
2014 Tartof SY, Tseng HF, Liu AL, Qian L, Sy LS, Hechter RC, Marcy SM, Jacobsen SJ. Exploring the risk factors for vaccine-associated and non-vaccine associated febrile seizures in a large pediatric cohort. Vaccine. 32: 2574-81. PMID 24674662 DOI: 10.1016/J.Vaccine.2014.03.044  0.361
2014 Hechter RC, Jacobsen SJ, Luo Y, Nomura JH, Towner WJ, Tartof SY, Tseng HF. Hepatitis B testing and vaccination among adults with sexually transmitted infections in a large managed care organization. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 58: 1739-45. PMID 24571863 DOI: 10.1093/Cid/Ciu103  0.368
2013 Hechter RC, Tartof SY, Jacobsen SJ, Smith N, Tseng HF. Trends and disparity in zoster vaccine uptake in a managed care population. Vaccine. 31: 4564-8. PMID 23928461 DOI: 10.1016/J.Vaccine.2013.07.053  0.346
2013 Tartof S, Cohn A, Tarbangdo F, Djingarey MH, Messonnier N, Clark TA, Kambou JL, Novak R, Diomandé FV, Medah I, Jackson ML. Identifying optimal vaccination strategies for serogroup A Neisseria meningitidis conjugate vaccine in the African meningitis belt. Plos One. 8: e63605. PMID 23671685 DOI: 10.1371/Journal.Pone.0063605  0.361
2013 Tartof SY, Lewis M, Kenyon C, White K, Osborn A, Liko J, Zell E, Martin S, Messonnier NE, Clark TA, Skoff TH. Waning immunity to pertussis following 5 doses of DTaP. Pediatrics. 131: e1047-52. PMID 23478868 DOI: 10.1542/Peds.2012-1928  0.346
2012 Ribeiro GS, Tartof SY, Oliveira DW, Guedes AC, Reis MG, Riley LW, Ko AI. Surgery for valvular heart disease: a population-based study in a Brazilian urban center. Plos One. 7: e37855. PMID 22666401 DOI: 10.1371/Journal.Pone.0037855  0.449
2012 Adams-Sapper S, Sergeevna-Selezneva J, Tartof S, Raphael E, An Diep B, Perdreau-Remington F, Riley LW. Globally dispersed mobile drug-resistance genes in Gram-negative bacterial isolates from patients with bloodstream infections in a US urban general hospital Journal of Medical Microbiology. 61: 968-974. PMID 22493279 DOI: 10.1099/Jmm.0.041970-0  0.495
2011 Tartof SY, Farrimond F, de Matos JA, Reis JN, Ramos RT, Andrade AN, dos Reis MG, Riley LW. Inverse association between Lancefield group G Streptococcus colonization and sore throat in slum and nonslum settings in Brazil. Journal of Clinical Microbiology. 49: 409-12. PMID 21048010 DOI: 10.1128/Jcm.02095-10  0.486
2010 Tartof SY, Reis JN, Andrade AN, Ramos RT, Reis MG, Riley LW. Factors associated with Group A Streptococcus emm type diversification in a large urban setting in Brazil: a cross-sectional study. Bmc Infectious Diseases. 10: 327. PMID 21070669 DOI: 10.1186/1471-2334-10-327  0.538
2007 Tartof SY, Solberg OD, Riley LW. Genotypic analyses of uropathogenic Escherichia coli based on fimH single nucleotide polymorphisms (SNPs). Journal of Medical Microbiology. 56: 1363-9. PMID 17893175 DOI: 10.1099/Jmm.0.47262-0  0.498
2005 Tartof SY, Solberg OD, Manges AR, Riley LW. Analysis of a uropathogenic Escherichia coli clonal group by multilocus sequence typing. Journal of Clinical Microbiology. 43: 5860-4. PMID 16333067 DOI: 10.1128/Jcm.43.12.5860-5864.2005  0.643
Show low-probability matches.